• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏再生中的核胆汁酸受体FXR

Nuclear bile acid receptor FXR in the hepatic regeneration.

作者信息

Chen Wei-Dong, Wang Yan-Dong, Meng Zhipeng, Zhang Lisheng, Huang Wendong

机构信息

Division of Gene Regulation & Drug Discovery, Beckman Research Institute, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA 91010, USA.

出版信息

Biochim Biophys Acta. 2011 Aug;1812(8):888-92. doi: 10.1016/j.bbadis.2010.12.006. Epub 2010 Dec 15.

DOI:10.1016/j.bbadis.2010.12.006
PMID:21167938
Abstract

The liver can fully regenerate itself by a compensatory regrowth in response to partial hepatectomy or injury. This process consists of a variety of well-orchestrated phases and is mediated by many signals. Farnesoid X receptor (FXR) is a member of the nuclear hormone receptor superfamily of ligand-activated transcription factors. Bile acids are FXR physiological ligands. As a metabolic regulator, FXR plays key roles in regulating metabolism of bile acids, lipids and glucose. Recently, bile acid/FXR signaling pathway is shown to be required for normal liver regeneration. Furthermore, FXR promotes liver repair after injury and activation of FXR is able to alleviate age-related defective liver regeneration. These novel findings suggest that FXR-mediated bile acid signaling is an integrated component of normal liver regeneration machinery, and also highlight the potential use of FXR ligands to promote liver regeneration after segmental liver transplantation or resection of liver tumors. This article is part of a Special Issue entitled: Translating nuclear receptors from health to disease.

摘要

肝脏能够通过代偿性再生对部分肝切除术或损伤做出反应,从而实现完全自我再生。这个过程由一系列精心编排的阶段组成,并由多种信号介导。法尼酯X受体(FXR)是配体激活转录因子的核激素受体超家族的成员。胆汁酸是FXR的生理性配体。作为一种代谢调节因子,FXR在调节胆汁酸、脂质和葡萄糖代谢中起关键作用。最近,胆汁酸/FXR信号通路被证明是正常肝脏再生所必需的。此外,FXR促进损伤后的肝脏修复,FXR的激活能够减轻与年龄相关的肝脏再生缺陷。这些新发现表明,FXR介导的胆汁酸信号是正常肝脏再生机制的一个组成部分,也突出了FXR配体在促进节段性肝移植或肝肿瘤切除术后肝脏再生方面的潜在用途。本文是名为:将核受体从健康转化为疾病的特刊的一部分。

相似文献

1
Nuclear bile acid receptor FXR in the hepatic regeneration.肝脏再生中的核胆汁酸受体FXR
Biochim Biophys Acta. 2011 Aug;1812(8):888-92. doi: 10.1016/j.bbadis.2010.12.006. Epub 2010 Dec 15.
2
Bile acid signaling and liver regeneration.胆汁酸信号传导与肝脏再生
Biochim Biophys Acta. 2015 Feb;1849(2):196-200. doi: 10.1016/j.bbagrm.2014.05.021. Epub 2014 May 27.
3
The role of bile salts in liver regeneration.胆汁盐在肝脏再生中的作用。
Hepatol Int. 2016 Sep;10(5):733-40. doi: 10.1007/s12072-016-9723-8. Epub 2016 Apr 5.
4
Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats.胆汁酸通过法尼酯X受体信号通路促进大鼠肝脏再生。
Mol Med Rep. 2015 Jun;11(6):4431-7. doi: 10.3892/mmr.2015.3270. Epub 2015 Jan 29.
5
FXR: a metabolic regulator and cell protector.法尼醇X受体:一种代谢调节因子和细胞保护剂。
Cell Res. 2008 Nov;18(11):1087-95. doi: 10.1038/cr.2008.289.
6
Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice.在小鼠的肝脏和肠道中,法尼醇 X 受体促进肝脏再生/修复。
Hepatology. 2012 Dec;56(6):2336-43. doi: 10.1002/hep.25905.
7
Insufficient bile acid signaling impairs liver repair in CYP27(-/-) mice.胆汁酸信号不足会损害 CYP27(-/-) 小鼠的肝脏修复。
J Hepatol. 2011 Oct;55(4):885-95. doi: 10.1016/j.jhep.2010.12.037. Epub 2011 Feb 18.
8
FXR, a target for different diseases.法尼醇X受体(FXR),一种针对多种疾病的靶点。
Histol Histopathol. 2008 May;23(5):621-7. doi: 10.14670/HH-23.621.
9
The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.法尼醇X受体(FXR)作为非酒精性脂肪性肝炎的新靶点。
Diabetes Metab. 2008 Dec;34(6 Pt 2):685-91. doi: 10.1016/S1262-3636(08)74605-6.
10
Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor.阿利松 B 23-醋酸酯通过激活法尼醇 X 受体促进小鼠肝部分切除术后的肝再生。
Biochem Pharmacol. 2014 Nov 15;92(2):289-98. doi: 10.1016/j.bcp.2014.09.009. Epub 2014 Sep 30.

引用本文的文献

1
Pharmacological Mechanisms of Bile Acids Targeting the Farnesoid X Receptor.胆汁酸靶向法尼醇X受体的药理机制
Int J Mol Sci. 2024 Dec 20;25(24):13656. doi: 10.3390/ijms252413656.
2
Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease.天然化合物在肝脏炎症性疾病中对 Nrf2 和 FXR 的激活作用。
Int J Mol Sci. 2024 Oct 18;25(20):11213. doi: 10.3390/ijms252011213.
3
Comparative Study on the Effects of Four Plant Protein Sources on the Liver and Intestinal Health of Largemouth Bass, .四种植物蛋白源对大口黑鲈肝脏和肠道健康影响的比较研究
Aquac Nutr. 2024 Jan 24;2024:6337005. doi: 10.1155/2024/6337005. eCollection 2024.
4
Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study.将 FDA 批准的药物重新用作 FXR 激动剂:基于结构的计算机药理学研究。
Biosci Rep. 2023 Mar 31;43(3). doi: 10.1042/BSR20212791.
5
Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.靶向肝脏X受体或法尼醇X受体的天然产物
Front Pharmacol. 2022 Jan 5;12:772435. doi: 10.3389/fphar.2021.772435. eCollection 2021.
6
Role of FGF15 in Hepatic Surgery in the Presence of Tumorigenesis: Dr. Jekyll or Mr. Hyde?成纤维细胞生长因子 15 在肿瘤发生时肝外科中的作用:是“化身博士”还是“两面人”?
Cells. 2021 Jun 7;10(6):1421. doi: 10.3390/cells10061421.
7
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.法尼醇 X 受体在代谢性疾病、胃肠道癌和肝癌中的作用。
Nat Rev Gastroenterol Hepatol. 2021 May;18(5):335-347. doi: 10.1038/s41575-020-00404-2. Epub 2021 Feb 10.
8
System analysis of cross-talk between nuclear receptors reveals an opposite regulation of the cell cycle by LXR and FXR in human HepaRG liver cells.核受体间串扰的系统分析揭示了 LXR 和 FXR 在人 HepaRG 肝细胞中对细胞周期的相反调节作用。
PLoS One. 2019 Aug 22;14(8):e0220894. doi: 10.1371/journal.pone.0220894. eCollection 2019.
9
Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis.肝切除术后胆汁酸稳态及肠-肝信号轴背景下的肝脏再生
J Clin Transl Res. 2018 May 28;4(1):1-46. doi: 10.18053/jctres.04.201801.001. Epub 2018 Feb 16.
10
Update on FXR Biology: Promising Therapeutic Target?FXR 生物学研究进展:有前途的治疗靶点?
Int J Mol Sci. 2018 Jul 16;19(7):2069. doi: 10.3390/ijms19072069.